Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections

References

• Penaranda C, Chumbler NM, Hung DT. Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection. PLoS Pathog. 2021;17(4):e1009534. doi:10.1371/journal.ppat.1009534
   PubMed Web of Science ®Google Scholar
• Lamas Ferreiro JL, Álvarez Otero J, González González L, et al. Pseudomonas aeruginosa urinary tract infections in hospitalized patients: mortality and prognostic factors. PLoS One. 2017;12(5):e0178178. doi:10.1371/journal.pone.0178178
   PubMed Web of Science ®Google Scholar
• Hu -Y-Y, Cao J-M, Yang Q, et al. Risk factors for carbapenem-resistant Pseudomonas aeruginosa, Zhejiang Province, China. Emerg Infect Dis. 2019;25(10):1861–1867. doi:10.3201/eid2510.181699
   PubMed Web of Science ®Google Scholar
• Wi YM, Choi J-Y, Lee J-Y, et al. Antimicrobial effects of β-lactams on imipenem-resistant ceftazidime-susceptible Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61(6):e00054–17. doi:10.1128/AAC.00054-17
   Web of Science ®Google Scholar
• Hu Y, Liu C, Wang Q, et al. Emergence and expansion of a carbapenem-resistant Pseudomonas aeruginosa clone are associated with plasmid-borne bla (KPC-2) and virulence-related genes. mSystems. 2021;6(3):e00154–121. doi:10.1128/mSystems.00154-21
   Web of Science ®Google Scholar
• Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177–192. doi:10.1016/j.biotechadv.2018.11.013
   PubMed Web of Science ®Google Scholar
• Yin S, Chen P, You B, et al. Molecular typing and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a Chinese Burn Center from 2011 to 2016. Front Microbiol. 2018;9:1135.
   PubMed Web of Science ®Google Scholar
• Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia. 2012;16(4):303–307.
   PubMed Web of Science ®Google Scholar
• Yoon E-J, Jeong SH. Mobile carbapenemase genes in Pseudomonas aeruginosa. Front Microbiol. 2021;12:614058. doi:10.3389/fmicb.2021.614058
   PubMed Web of Science ®Google Scholar
• Sultan M, Arya R, Kim KK. Roles of two-component systems in Pseudomonas aeruginosa virulence. Int J Mol Sci. 2021;22(22):12152. doi:10.3390/ijms222212152
   PubMed Web of Science ®Google Scholar
• Horii T, Muramatsu H, Monji A, Miyagishima D. Release of exotoxin A, peptidoglycan and endotoxin after exposure of clinical Pseudomonas aeruginosa isolates to carbapenems in vitro. Chemotherapy. 2005;51(6):324–331. doi:10.1159/000088955
   Web of Science ®Google Scholar
• Galle M, Jin S, Bogaert P, Haegman M, Vandenabeele P, Beyaert R. The Pseudomonas aeruginosa type III secretion system has an exotoxin S/T/Y independent pathogenic role during acute lung infection. PLoS One. 2012;7(7):e41547. doi:10.1371/journal.pone.0041547
   PubMed Web of Science ®Google Scholar
• Newman JW, Floyd RV, Fothergill JL. The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections. FEMS Microbiol Lett. 2017;364:15. doi:10.1093/femsle/fnx124
   Web of Science ®Google Scholar
• Lee VT, Pukatzki S, Sato H, et al. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun. 2007;75(3):1089–1098. doi:10.1128/IAI.01184-06
   Web of Science ®Google Scholar
• Chadha J, Harjai K, Chhibber S. Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environ Microbiol. 2021. doi:10.1111/1462-2920.15784
   Web of Science ®Google Scholar
• Bashir A, Tian T, Yu X, Meng C, Ali M, Li L. Pyoverdine-mediated killing of Caenorhabditis elegans by Pseudomonas syringae MB03 and the role of iron in its pathogenicity. Int J Mol Sci. 2020;21(6):2198. doi:10.3390/ijms21062198
   Web of Science ®Google Scholar
• Behzadi P, Baráth Z, Gajdács M. It’s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 2021;10(1):42. doi:10.3390/antibiotics10010042
   Web of Science ®Google Scholar
• Gohain N. Studies on the structure and function of phenazine modifying enzymes PhzM and PhzS involved in the biosynthesis of pyocyanin; 2009.
   Google Scholar
• Bogiel T, Depka D, Rzepka M, Kwiecińska-Piróg J, Gospodarek-Komkowska E. Prevalence of the genes associated with biofilm and toxins synthesis amongst the Pseudomonas aeruginosa clinical strains. Antibiotics. 2021;10(3):241. doi:10.3390/antibiotics10030241
   Web of Science ®Google Scholar
• Osawa K, Shigemura K, Kitagawa K, et al. Molecular characteristics of carbapenem-resistant Pseudomonas aeruginosa isolated from urine in Hyogo, Japan. Int J Urol. 2019;26(1):127–133. doi:10.1111/iju.13818
   Web of Science ®Google Scholar
• Del Barrio-Tofiño E, López-Causapé C, Oliver A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. Int J Antimicrob Agents. 2020;56(6):106196. doi:10.1016/j.ijantimicag.2020.106196
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Disk Susceptibility Testing, 30th M100. PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644–5649. doi:10.1128/JCM.42.12.5644-5649.2004
   PubMed Web of Science ®Google Scholar
• Hong JS, Yoon E-J, Lee H, Jeong SH, Lee K. Clonal dissemination of Pseudomonas aeruginosa sequence type 235 isolates carrying blaIMP-6 and emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and −16 in South Korea. Antimicrob Agents Chemother. 2016;60(12):7216–7223. doi:10.1128/AAC.01601-16
   PubMed Web of Science ®Google Scholar
• Meradji S, Barguigua A, Zerouali K, et al. Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria. Antimicrob Resist Infect Control. 2015;4:27. doi:10.1186/s13756-015-0067-2
   Web of Science ®Google Scholar
• El-Mahdy R, El-Kannishy G. Virulence factors of carbapenem-resistant Pseudomonas aeruginosa in hospital-acquired infections in Mansoura, Egypt. Infect Drug Resist. 2019;12:3455–3461. doi:10.2147/IDR.S222329
   Web of Science ®Google Scholar
• Gajdács M, Kárpáti K, Stájer A, Zanetti S, Matthew Gavino D. Insights on carbapenem-resistant Pseudomonas aeruginosa: phenotypic characterization of relevant isolates. Acta Biologica Szegediensis. 2021;65(1):105–112. doi:10.14232/abs.2021.1.105-112
   Google Scholar
• Gonçalves IR, Dantas RC, Ferreira ML, Batistão DW, Gontijo-Filho PP, Ribas RM. Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation. Braz J Microbiol. 2017;48(2):211–217. doi:10.1016/j.bjm.2016.11.004
   Web of Science ®Google Scholar
• Hong DJ, Bae IK, Jang I-H, Jeong SH, Kang H-K, Lee K. Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa. Infect Chemother. 2015;47(2):81–97. doi:10.3947/ic.2015.47.2.81
   PubMed Web of Science ®Google Scholar
• Ohadian Moghadam S, Afshar D, Nowroozi MR, Behnamfar A, Farzin A. Molecular epidemiology of carbapenemase-producing Pseudomonas aeruginosa isolated from an Iranian University Hospital: evidence for spread of high-risk clones. Infect Drug Resist. 2020;13:1583–1592. doi:10.2147/IDR.S253756
   Web of Science ®Google Scholar
• Hammoudi Halat D, Ayoub Moubareck C. The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria. Antibiotics. 2020;9(4):186. doi:10.3390/antibiotics9040186
   Web of Science ®Google Scholar
• Hong JS, Song W, Park M-J, Jeong S, Lee N, Jeong SH. Molecular characterization of the first emerged ndm-1-producing Pseudomonas aeruginosa isolates in South Korea. Microb Drug Resist. 2021;27(8):1063–1070. doi:10.1089/mdr.2020.0374
   Web of Science ®Google Scholar
• Hong JS, Kim JO, Lee H, Bae IK, Jeong SH, Lee K. Characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa in Korea. Infect Chemother. 2015;47(1):33–40. doi:10.3947/ic.2015.47.1.33
   PubMed Web of Science ®Google Scholar
• Walters MS, Grass JE, Bulens SN, et al. Carbapenem-resistant Pseudomonas aeruginosa at US emerging infections program sites, 2015. Emerg Infect Dis. 2019;25(7):1281–1288. doi:10.3201/eid2507.181200
   PubMed Web of Science ®Google Scholar
• Treepong P, Kos VN, Guyeux C, et al. Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Clin Microbiol Infect. 2018;24(3):258–266. doi:10.1016/j.cmi.2017.06.018
   PubMed Web of Science ®Google Scholar
• Kocsis B, Toth A, Gulyas D, et al. Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 clone. J Med Microbiol. 2019;68(3):336–338. doi:10.1099/jmm.0.000927
   Web of Science ®Google Scholar
• Seok Y, Bae IK, Jeong SH, Kim SH, Lee H, Lee K. Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea. J Antimicrob Chemother. 2011;66(12):2791–2796. doi:10.1093/jac/dkr381
   PubMed Web of Science ®Google Scholar
• Khan A, Shropshire WC, Hanson B, et al. Simultaneous infection with Enterobacteriaceae and Pseudomonas aeruginosa harboring multiple carbapenemases in a returning traveler colonized with candida auris. Antimicrob Agents Chemother. 2020;64(2):e01466–1419. doi:10.1128/AAC.01466-19
   Web of Science ®Google Scholar
• Ellappan K, Belgode Narasimha H, Kumar S. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India. J Glob Antimicrob Resist. 2018;12:37–43. doi:10.1016/j.jgar.2017.08.018
   Web of Science ®Google Scholar
• Gajdács M, Baráth Z, Kárpáti K, et al. No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics. 2021;10(9):1134. doi:10.3390/antibiotics10091134
   Web of Science ®Google Scholar
• Azimi S, Kafil HS, Baghi HB, et al. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran. GMS Hyg Infect Control. 2016;11:Doc04. doi:10.3205/dgkh000264
   Google Scholar
• Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009;7(9):654–665. doi:10.1038/nrmicro2199
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Peck K, Ko KS. Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilm-forming activity. J Med Microbiol. 2013;62(7):1015–1024. doi:10.1099/jmm.0.055426-0
   Web of Science ®Google Scholar
• Alonso B, Fernández-Barat L, Di Domenico EG, et al. Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia. BMC Infect Dis. 2020;20(1):909. doi:10.1186/s12879-020-05534-1
   PubMed Web of Science ®Google Scholar
• Bogiel T, Prażyńska M, Kwiecińska-Piróg J, Mikucka A, Gospodarek-Komkowska E. Carbapenem-resistant Pseudomonas aeruginosa strains-distribution of the essential enzymatic virulence factors genes. Antibiotics. 2020;10(1):8. doi:10.3390/antibiotics10010008
   Web of Science ®Google Scholar
• Pobiega M, Maciag J, Pomorska-Wesolowska M, et al. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: virulence factors and antibiotic resistance. J Pediatr Urol. 2016;12(1):36.e31–36. doi:10.1016/j.jpurol.2015.05.034
   Web of Science ®Google Scholar
• Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health. 2009;2(3):101–111. doi:10.1016/j.jiph.2009.08.003
   PubMedGoogle Scholar
• Visca P, Imperi F, Lamont IL. Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol. 2007;15(1):22–30. doi:10.1016/j.tim.2006.11.004
   PubMed Web of Science ®Google Scholar
• Tielen P, Narten M, Rosin N, et al. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int J Med Microbiol. 2011;301(4):282–292. doi:10.1016/j.ijmm.2010.10.005
   PubMed Web of Science ®Google Scholar